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Introduction. Cardiovascular disease is a general term for conditions affecting the heart and 
circulation. It is the number one cause of death globally. It is predicted that the annual incidence 
of cardiovascular disease - related mortalities will rise to 23,3 million globally by 2030. 
Developed disorders are often associated with the narrowing or blockage of the luminal diameter 
leading to inhibited blood flow through the affected vessels and tissue damage due to inadequate 
nutrient supply. The treatment options depend on the type of condition the person has and may 
range from dietary and lifestyle modification to pharmaceutical therapies and endovascular or 
surgical interventions. 
Despite advantages and increased popularity of endovascular surgery, the preferred treatment for 
the long term revascularization is surgery utilizing vascular grafts. Currently available conduits 
for vascular grafting do not satisfy completely surgeons’ requirements due to poor clinical 
efficacy, especially in small diameter vessels applications (< 6 mm). Therefore, tissue-
engineered materials are the only alternative solution through the generation of biologically 
based functional vessels.  
Aim of the study. To provide an overview of decellularization techniques employed current to 
produce a clinically viable tissue-engineered vascular grafts; to highlight both benefits and 
drawbacks of each strategy.  
Materials and methods. Articles containing the keywords: Cardiovascular disease; Tissue-
engineered vascular grafts (TEVG); Vessel decellularization; Decellularization reagents; 
Mechanical properties of vessel substitutes were selected from the PubMed and Springer Link 
databases.  
Results. The use of biological scaffolds composed by extracellular matrix (ECM) as a strategy 
for tissue or organ replacement has increased. One technique that has shown good results in 
several tissue engineering applications, including blood vessels, is the use of decellularized 
scaffolds. Decellularization is the complete removal of all cellular and nuclear matters from a 
tissue while preserving ECM, and can be done by using detergents, enzymatic digestion, or 
mechanical stimulation. Decelullarization process induces the loos of the major 
histocompatibility complex while avoiding any adverse immunological reactions by the host. It 
allows the use of decellularized biological tissue not only as autografts but also as allografts and 
xenografts.  
Conclusions. It is confirmed that the decellularization process is suitable for the generation of 
acellular scaffolds for vascular tissue engineering applications. However, the best technique that 
allows the preservation physicochemical properties similar to fresh vessels is yet to be 
determined. Researches and clinical trials should be continued in this field. 
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Introduction. Hirsutism is the exaggerated increase of terminal hair in women, developing a 
male model. Hirsutism is an important medical problem, not just a cosmetic defect, which 
currently affects about 5-15% of women. The researchers have shown that the impact of 
hirsutism symptoms on a woman's quality of life can be profound and can lead to psychological 
stress that threatens her feminine identity. Despite a large number of published works, some 
aspects of hirsutism are still controversial or underestimated. The treatment of hirsutism often 
requires a multidisciplinary approach and a variety of physical or pharmacological modalities 
can be used with the combination of 2 or more drugs in combination with esthetic treatment, 
depending on the involved etiopathogenetic mechanism. 
Aim of the study. Evaluation of the molecular-genetic bases of hirsutism, the study of clinical 
polymorphism and the management of women with hirsutism. 
Materials and methods. Online databases, meta-analyzes, scientific papers in theoretical and 
practical medicine were used. 
Results. Following the analyses of the scientific papers we highlighted the main etiological 
factors of hirsutism: ovarian (93% PCOS, <1% androgendependent tumors, <1% luteoma); 
adrenals (<1% CAH, <1% Cushing syndrome, <1% androgen secretory tumors, 1% acromegaly) 
and other external factors (<1% iatrogenic, <1% androgenic drugs). The genetic approach has 
noted the involvement in the development of hirsutism of mutations in 5 major genes encoding 
important enzymes in androgen metabolism: 21-hydroxylase, P450 cytochrome oxidoreductase, 
aromatase, 11-beta-hydroxylase, 5 alpha reductase. The diagnosis of hirsutism is based on a 
detailed anamnesis, the objective exam using the Ferriman-Galway scale, seric markers, 
additional genetic and paraclinical tests. Ovarian suppression of androgens secretion with oral 
contraceptives is widely used in these women, but its efficacy is limited. One of the most 
effective medical therapies for hirsutism is medication with anti-androgens (spironolactone, 
finasteride, flutamide, etc.)  
Conclusions. Hirsutism is a current medical problem that affects women's quality of life. PCOS 
(polycystic ovary syndrome) is the most common cause of hirsutism. The management of a 
woman with hirsutism requires a multidisciplinary approach - family doctor, endocrinologist, 
gynecologist, dermatologist. The treatment is indicated according to the ethiopathological, 
individualized mechanism, treatment strategies can be included with the combination of 2 or 
more drugs. Aesthetic and maintenance treatment is not excluded.  
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Introduction. Female infertility is defined as the inability to conceive after one year of regular 
unprotected intercourse for women younger than 35 years and within 6 months for women after 
35 years. One in seven couples experiences infertility or subfertility, and in 40% of cases it is 
because of women. Clinically, female infertility is a highly heterogeneous pathology with a 
complex etiology that includes environmental and genetic factors. It is difficult to assess 
accurately the overall magnitude of the contribution of the genetics to female infertility as most, 
if not all, conditions are likely to have a genetic component. Nethertheless, a significant number 
of infertility phenotypes have been associated with specific genetic anomalies.  
Aim of the study. - This review aims to summarize current research on genetic diagnosis and 
genetic causes of female infertility.  
